BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2526123)

  • 21. Differential glycosylation of the 5A11/HT7 antigen by neural retina and epithelial tissues in the chicken.
    Fadool JM; Linser PJ
    J Neurochem; 1993 Apr; 60(4):1354-64. PubMed ID: 8455029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand-induced phosphorylation of the human interferon-gamma receptor. Dependence on the presence of a functionally active receptor.
    Hershey GK; McCourt DW; Schreiber RD
    J Biol Chem; 1990 Oct; 265(29):17868-75. PubMed ID: 2145277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The murine interleukin 2 receptor. IV. Biochemical characterization.
    Malek TR; Korty PE
    J Immunol; 1986 Jun; 136(11):4092-8. PubMed ID: 3084653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel IFN-gamma regulated human melanoma associated antigen gp33-38 defined by monoclonal antibody Me14/D12. I. Identification and immunochemical characterization.
    Giuffré L; Isler P; Mach JP; Carrel S
    J Immunol; 1988 Sep; 141(6):2072-8. PubMed ID: 3139751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
    Li JG; Chen C; Liu-Chen LY
    Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aortic smooth muscle contains guanylate-cyclase-coupled 130-kDa atrial natriuretic factor receptor as predominant receptor form. Spontaneous switching to 60-kDa C-receptor upon cell culturing.
    Abe T; Nishiyama K; Snajdar R; He X; Misono KS
    Eur J Biochem; 1993 Oct; 217(1):295-304. PubMed ID: 7901005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 25-kDa stretch of the extracellular domain of the human interferon gamma receptor is required for full ligand binding capacity.
    Fountoulakis M; Lahm HW; Maris A; Friedlein A; Manneberg M; Stueber D; Garotta G
    J Biol Chem; 1991 Aug; 266(23):14970-7. PubMed ID: 1831199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human interferon-gamma receptor. Purification, characterization, and preparation of antibodies.
    Novick D; Orchansky P; Revel M; Rubinstein M
    J Biol Chem; 1987 Jun; 262(18):8483-7. PubMed ID: 2954953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of murine interferon-gamma binding to its receptor on intact cells and solubilized membranes. Identification of an 80 kDa receptor.
    Cofano F; Landolfo S; Appella E; Ullrich SJ
    FEBS Lett; 1989 Jan; 242(2):233-6. PubMed ID: 2521607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biosynthesis and acquisition of biological activity of the fibronectin receptor.
    Akiyama SK; Yamada KM
    J Biol Chem; 1987 Dec; 262(36):17536-42. PubMed ID: 2961737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in glycosylation alter the affinity of the human transferrin receptor for its ligand.
    Hunt RC; Riegler R; Davis AA
    J Biol Chem; 1989 Jun; 264(16):9643-8. PubMed ID: 2722854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co- and posttranslational modification of the alpha(1B)-adrenergic receptor: effects on receptor expression and function.
    Björklöf K; Lundström K; Abuin L; Greasley PJ; Cotecchia S
    Biochemistry; 2002 Apr; 41(13):4281-91. PubMed ID: 11914074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and biochemical characterization of a soluble human interferon gamma receptor expressed in Escherichia coli.
    Fountoulakis M; Juranville JF; Stüber D; Weibel EK; Garotta G
    J Biol Chem; 1990 Aug; 265(22):13268-75. PubMed ID: 2142945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of the human interferon-gamma receptor: analysis of polymorphism and glycosylation.
    Mao C; Aguet M; Merlin G
    J Interferon Res; 1989 Dec; 9(6):659-69. PubMed ID: 2532662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration and partial characterization of the interferon-gamma receptor on human mononuclear phagocytes.
    Celada A; Allen R; Esparza I; Gray PW; Schreiber RD
    J Clin Invest; 1985 Dec; 76(6):2196-205. PubMed ID: 2934408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the human type I interferon receptor by ligand blotting.
    Schwabe M; Princler GL; Faltynek CR
    Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biosynthesis and secretion of acid phosphatase by Leishmania donovani promastigotes.
    Bates PA; Dwyer DM
    Mol Biochem Parasitol; 1987 Dec; 26(3):289-96. PubMed ID: 3323906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthesis and processing of the mannose receptor in human macrophages.
    Lennartz MR; Cole FS; Stahl PD
    J Biol Chem; 1989 Feb; 264(4):2385-90. PubMed ID: 2914913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass spectrometric characterization of glycosylated interferon-gamma variants separated by gel electrophoresis.
    Mørtz E; Sareneva T; Haebel S; Julkunen I; Roepstorff P
    Electrophoresis; 1996 May; 17(5):925-31. PubMed ID: 8783018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture.
    Curling EM; Hayter PM; Baines AJ; Bull AT; Gull K; Strange PG; Jenkins N
    Biochem J; 1990 Dec; 272(2):333-7. PubMed ID: 2125204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.